1. Home
  2. ACU vs PLX Comparison

ACU vs PLX Comparison

Compare ACU & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$47.86

Market Cap

160.6M

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.28

Market Cap

168.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
PLX
Founded
1867
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.6M
168.4M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
ACU
PLX
Price
$47.86
$2.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$50.00
$12.00
AVG Volume (30 Days)
11.0K
568.8K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
1.56%
N/A
EPS Growth
1.63
N/A
EPS
0.24
0.22
Revenue
$196,541,816.00
$52,744,000.00
Revenue This Year
$5.67
$36.81
Revenue Next Year
$5.25
N/A
P/E Ratio
$198.17
$10.09
Revenue Growth
1.05
N/A
52 Week Low
$35.50
$1.36
52 Week High
$47.56
$3.19

Technical Indicators

Market Signals
Indicator
ACU
PLX
Relative Strength Index (RSI) 74.41 65.41
Support Level $40.57 $2.06
Resistance Level N/A $2.42
Average True Range (ATR) 1.58 0.09
MACD 0.40 0.03
Stochastic Oscillator 86.58 88.89

Price Performance

Historical Comparison
ACU
PLX

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: